Nrf2-deficient mice are more susceptible to carcinogen-induced cancers [20] and develop more severe intestinal inflammation and a higher number of aberrant crypts than controls upon dextran sulfate sodium treatment [21–23]. Here, NFE2L2 is linked to cancer.